Icon

TOBI (nda050753)- (300MG/5ML)

TOBRAMYCIN MYLAN SPECIALITY LP
300MG/5ML
Yes No
2014-Oct-19 Expired
None None
None No
TOBI is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.
9 0 9
Total Other Developers 13
Drugs with Suitability No
300MG/5ML ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** ****** ********** ******* *********** ***** **** *****, ********** **** ********** ******, ******* *****, *******, ******** *** ***, ****** ******* (***) ***
****** ***** *** ******** *********** *********** * ********** ******, ********, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** ***************, *** *********** * *** ******* *** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ******** ****** *********, *** *********** **** ********** *****, **********, ******** (**) *****, ****** ****** (***) ***
****** ** ****** **** ** ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** *** ***** *** ************** ******** ******* *********** ****** **. ** *** ** - ******* :- ***** **** - *****, ***** **********, ******* ******, ***** (***) ***
****** ***** **** *** ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** ***-***, ** *****, ****** **** ****, *****, *********** ********** ****, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.